Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Author(s):
Maksymowych, W.; Landewe, R.; Rudwaleit, M.; Heijde, D. van der; Dougados, M.; Mease, P.; Reveille, J.; Walsh, J.; Kivitz, A.; Braun, J.; Deodhar, A.; Stach, C.; Hoepken, B.; Singh, P.; Sieper, J.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-07-31
Language
English
Is part of
Journal of Rheumatology (2014), Vol. 41, no. 7, p. 1496-1497
